Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $588.8 million.

  • Conmed's Retained Earnings rose 508.48% to $588.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $588.8 million, marking a year-over-year increase of 508.48%. This contributed to the annual value of $588.8 million for FY2025, which is 508.48% up from last year.
  • Per Conmed's latest filing, its Retained Earnings stood at $588.8 million for Q4 2025, which was up 508.48% from $572.0 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Retained Earnings ranged from a high of $588.8 million in Q4 2025 and a low of -$62.8 million during Q1 2021
  • Over the past 5 years, Conmed's median Retained Earnings value was -$52.9 million (recorded in 2022), while the average stood at $208.7 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first crashed by 674.32% in 2022, then soared by 108723.29% in 2024.
  • Over the past 5 years, Conmed's Retained Earnings (Quarter) stood at -$54.2 million in 2021, then decreased by 6.74% to -$57.9 million in 2022, then surged by 882.14% to $452.5 million in 2023, then increased by 23.81% to $560.3 million in 2024, then grew by 5.08% to $588.8 million in 2025.
  • Its last three reported values are $588.8 million in Q4 2025, $572.0 million for Q3 2025, and $575.4 million during Q2 2025.